Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.25 USD | +13.78% | +15.66% | +186.11% |
06:04pm | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
03:20pm | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+186.11% | 939M | |
+7.63% | 111B | |
+11.32% | 106B | |
-12.35% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.69% | 16.81B | |
+38.54% | 12.54B | |
-24.35% | 8.09B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Arcutis Biotherapeutics : Mizuho Securities Starts Arcutis Biotherapeutics at Buy With $58 Price Target